According to Cytosorbents's latest financial reports the company has ยฃ4.4 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | ยฃ11.09 M | -39.4% |
2022-12-31 | ยฃ18.3 M | -52.61% |
2021-12-31 | ยฃ38.62 M | -26.28% |
2020-12-31 | ยฃ52.39 M | 461.7% |
2019-12-31 | ยฃ9.32 M | -47.06% |
2018-12-31 | ยฃ17.62 M | 37.49% |
2017-12-31 | ยฃ12.81 M | 201.51% |
2016-12-31 | ยฃ4.25 M | -16.11% |
2015-12-31 | ยฃ5.06 M | 42.14% |
2014-12-31 | ยฃ3.56 M | 169.35% |
2013-12-31 | ยฃ1.32 M | 23.69% |
2012-12-31 | ยฃ1.06 M | 40.14% |
2011-12-31 | ยฃ0.76 M | 11.64% |
2010-12-31 | ยฃ0.68 M | -30.65% |
2009-12-31 | ยฃ0.98 M | -50.99% |
2008-12-31 | ยฃ2.01 M | 1788.86% |
2007-12-31 | ยฃ0.1 M | -92.74% |
2006-12-31 | ยฃ1.46 M |